Obesity
Conference Coverage
Noninfected children of HIV-positive mothers have high rates of obesity
NEW ORLEANS – Obesity and reactive airway disease are more prevalent in noninfected children of HIV-positive mothers.
News
In obesity-related asthma, a new hormonal target
NEW ORLEANS – The puzzle pieces are coming together for the fatty acid binding protein 4, aP2.
From the Journals
Novel microbiome signature may detect NAFLD-cirrhosis
The microbial biomarker showed strong diagnostic accuracy for identifying cirrhosis in patients with NAFLD.
Conference Coverage
First RCT with aromatase inhibitor for male hypogonadism shows promise
NEW ORLEANS – In hypogonadism, an experimental aromatase inhibitor increased testosterone without reducing semen quality.
Conference Coverage
Hyperglycemia drives leaky gut syndrome, inflammation
MIAMI - HbA1c strongly correlated with the influx of microbial molecules in humans. Correcting hyperglycemia prevented enteric infections and...
From the Journals
For patients with end-stage liver disease, acute care incurs steep costs
Mean end-of-life costs exceeded those for ischemic heart disease, diabetes, mental health disorders, and congestive heart failure. Only chronic...
From the Journals
Supplements and food-related therapy do not prevent depression in overweight adults
Findings highlight that care incorporating psychological, pharmacologic, and lifestyle interventions “may have a more robust effect” on depression...
News
FDA accepts supplemental New Drug Application to expand lorcaserin label
The application is based on the CAMELLIA-TIMI-61 trial results.
Latest News
Roux-en-Y achieves diabetes remission in majority of patients
About three-quarters of patients with type 2 diabetes mellitus achieve remission after Roux-en-Y gastric bypass surgery.
From the Journals
Obesity-related cancers increasing in younger adults
Half of obesity-related cancers have increased in incidence among younger adults over the past two decades.
Conference Coverage
Oral GLP-1 receptor agonist pioneered in T2DM trial
BERLIN – Oral semaglutide was superior to placebo in reducing glycated hemoglobin at all doses tested, with weight loss benefits at the highest...